Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome.

Using its unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer. deCODE employs its capabilities to develop DNA-based tests and personal genome scans to better understand individual risk and empower prevention.

It also licenses its tests and intellectual property to partners, and provides leading- edge contract services to companies and research institutions around the globe. The company also has a therapeutic portfolio, which it intends to partner or directly outlicense these programs for further clinical development.